ALEX SU: Open Payments
NPI 1609871706 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,886 in 109 payments from 25 companies in 2025. Trend: 2023 $4,085 · 2024 $3,189 · 2025 $2,886
Food & beverage: $2,886
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 21 | $555 |
| AstraZeneca Pharmaceuticals LP | 6 | $400 |
| Amgen Inc. | 11 | $335 |
| Lilly USA, LLC | 11 | $266 |
| Phathom Pharmaceuticals, Inc. | 2 | $251 |
| PFIZER INC. | 15 | $204 |
| Exact Sciences Corporation | 8 | $156 |
| ABIOMED | 4 | $106 |
| GlaxoSmithKline, LLC. | 4 | $84 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $83 |
Products named: Ozempic, REPATHA, VOQUEZNA, AIRSUPRA, NURTEC ODT, Cologuard Collection Kit, BREZTRI, MOUNJARO.
Industry payments across TX — which companies pay providers there.
